SMT201900530T1 - A soluble chimeric interleukin-10 receptor and therapeutic use thereof - Google Patents

A soluble chimeric interleukin-10 receptor and therapeutic use thereof

Info

Publication number: SMT201900530T1
Authority: SM; San Marino
Prior art keywords: receptor; therapeutic use; soluble chimeric; chimeric interleukin; interleukin
Prior art date: 2015-04-29

Application number

SM20190530T

Other languages

Italian (it)

Inventor

Gilberto Filaci

Daniela Fenoglio

Francesca Ferrera

Original Assignee

Mediolanum Farm S P A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-29

Filing date

2016-04-26

Publication date

2019-11-13

2016-04-26 Application filed by Mediolanum Farm S P A filed Critical Mediolanum Farm S P A

2019-11-13 Publication of SMT201900530T1 publication Critical patent/SMT201900530T1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Epidemiology (AREA)

SM20190530T 2015-04-29 2016-04-26 A soluble chimeric interleukin-10 receptor and therapeutic use thereof SMT201900530T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITUB20150391		2015-04-29
EP16728097.3A EP3288965B1 (en)	2015-04-29	2016-04-26	A soluble chimeric interleukin-10 receptor and therapeutic use thereof
PCT/IB2016/052359 WO2016174575A1 (en)	2015-04-29	2016-04-26	A soluble chimeric interleukin-10 receptor and therapeutic use thereof

Publications (1)

Publication Number	Publication Date
SMT201900530T1 true SMT201900530T1 (en)	2019-11-13

Family

ID=53765409

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM20190530T SMT201900530T1 (en)	2015-04-29	2016-04-26	A soluble chimeric interleukin-10 receptor and therapeutic use thereof

Country Status (16)

Country	Link
US (1)	US20180086809A1 (en)
EP (1)	EP3288965B1 (en)
JP (1)	JP2018518945A (en)
KR (1)	KR20170138569A (en)
CN (1)	CN107531771A (en)
CA (1)	CA2979973A1 (en)
CY (1)	CY1122061T1 (en)
DK (1)	DK3288965T3 (en)
ES (1)	ES2744342T3 (en)
HK (1)	HK1245814B (en)
HU (1)	HUE046343T2 (en)
PL (1)	PL3288965T3 (en)
PT (1)	PT3288965T (en)
SI (1)	SI3288965T1 (en)
SM (1)	SMT201900530T1 (en)
WO (1)	WO2016174575A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN118307682A (en)	2016-09-27	2024-07-09	埃皮辛特瑞柯斯公司	Immunomodulatory fusion protein
CA3077223A1 (en) *	2017-09-27	2019-04-04	Epicentrx, Inc.	Immunomodulatory fusion proteins
EP3930687A4 (en)	2019-02-25	2023-06-07	The University of Chicago	METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES INVOLVING PEPTIDES WITH AN AFFINITY FOR THE EXTRACELLULAR MATRIX BONDED TO ANTI-INFLAMMATORY AGENTS
AU2021236879A1 (en) *	2020-03-16	2022-11-10	Vrije Universiteit Brussel	A mixture of mRNA to enhance the potency of dendritic cells
CN116162149A (en) *	2022-12-06	2023-05-26	苏州绶草生物科技有限公司	A method for increasing the gene expression of synthetic recombinant human serum albumin in plants
CN116125074A (en) *	2022-12-13	2023-05-16	北京东方百泰生物科技股份有限公司	A method for detecting the binding activity of IL-10-Fc fusion protein and its receptor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5789192A (en) *	1992-12-10	1998-08-04	Schering Corporation	Mammalian receptors for interleukin-10 (IL-10)
US6165476A (en) *	1997-07-10	2000-12-26	Beth Israel Deaconess Medical Center	Fusion proteins with an immunoglobulin hinge region linker
AU2001261024A1 (en) *	2000-04-12	2001-10-30	Delta Biotechnology Limited	Albumin fusion proteins
JP4635255B2 (en) *	2003-09-02	2011-02-23	独立行政法人産業技術総合研究所	Antibody medicine
ES2438098T3 (en) *	2003-11-13	2014-01-15	Hanmi Science Co., Ltd.	Pharmaceutical composition comprising an immunoglobulin Fc as a vehicle
ES2415604T3 (en) *	2007-05-30	2013-07-26	Postech Academy-Industry- Foundation	Immunoglobulin Fusion Proteins
NO2344540T3 (en) *	2008-10-02	2018-04-28
ES2670442T3 (en) *	2012-05-25	2018-05-30	Janssen Biotech, Inc.	Unnatural consensus albumin binding domains

2016
- 2016-04-26 PT PT167280973T patent/PT3288965T/en unknown
- 2016-04-26 SI SI201630348T patent/SI3288965T1/en unknown
- 2016-04-26 SM SM20190530T patent/SMT201900530T1/en unknown
- 2016-04-26 CA CA2979973A patent/CA2979973A1/en not_active Abandoned
- 2016-04-26 DK DK16728097.3T patent/DK3288965T3/en active
- 2016-04-26 WO PCT/IB2016/052359 patent/WO2016174575A1/en not_active Ceased
- 2016-04-26 US US15/562,557 patent/US20180086809A1/en not_active Abandoned
- 2016-04-26 HU HUE16728097A patent/HUE046343T2/en unknown
- 2016-04-26 ES ES16728097T patent/ES2744342T3/en active Active
- 2016-04-26 CN CN201680024854.0A patent/CN107531771A/en active Pending
- 2016-04-26 EP EP16728097.3A patent/EP3288965B1/en active Active
- 2016-04-26 JP JP2017556722A patent/JP2018518945A/en active Pending
- 2016-04-26 HK HK18105461.9A patent/HK1245814B/en not_active IP Right Cessation
- 2016-04-26 PL PL16728097T patent/PL3288965T3/en unknown
- 2016-04-26 KR KR1020177034625A patent/KR20170138569A/en not_active Withdrawn
2019
- 2019-09-23 CY CY20191100997T patent/CY1122061T1/en unknown

Also Published As

Publication number	Publication date
HK1245814B (en)	2020-06-19
CN107531771A (en)	2018-01-02
EP3288965A1 (en)	2018-03-07
JP2018518945A (en)	2018-07-19
PL3288965T3 (en)	2019-11-29
PT3288965T (en)	2019-10-15
SI3288965T1 (en)	2019-10-30
CA2979973A1 (en)	2016-11-03
US20180086809A1 (en)	2018-03-29
DK3288965T3 (en)	2019-09-23
EP3288965B1 (en)	2019-06-26
KR20170138569A (en)	2017-12-15
HUE046343T2 (en)	2020-02-28
WO2016174575A1 (en)	2016-11-03
ES2744342T3 (en)	2020-02-24
CY1122061T1 (en)	2020-11-25

Publication	Publication Date	Title
IL250685A0 (en)	2017-04-30	Cytotoxicity-inducing therapeutic agent
GB201403093D0 (en)	2014-04-09	Therapeutic compounds and their use
SI3132034T1 (en)	2020-12-31	Therapeutic
IL247072A0 (en)	2016-09-29	Medical use
IL250990A0 (en)	2017-04-30	Human therapeutic agents
GB201410216D0 (en)	2014-07-23	Therapeutic
SI3288965T1 (en)	2019-10-30	A soluble chimeric interleukin-10 receptor and therapeutic use thereof
GB201502412D0 (en)	2015-04-01	Therapeutic use
GB201608797D0 (en)	2016-07-06	Therapeutic use
GB201720992D0 (en)	2018-01-31	A medical use
GB201700526D0 (en)	2017-03-01	Therapeutic use
GB201510637D0 (en)	2015-07-29	Therapeutic
GB201506786D0 (en)	2015-06-03	Therapeutic use
GB2568266B (en)	2022-06-22	Therapeutic device
GB2554997B (en)	2021-01-13	A therapeutic bed
IL232605A0 (en)	2014-08-31	Flexible articulated device
GB201410334D0 (en)	2014-07-23	Therapeutic
ZA201703580B (en)	2018-08-29	Therapeutic homodimer and uses thereof
AU201713986S (en)	2017-09-12	Patient interface
AU201712841S (en)	2017-07-14	Patient interface
AU201711184S (en)	2017-05-15	Patient interface
GB201516494D0 (en)	2015-11-04	New therapeutic use
GB201415302D0 (en)	2014-10-15	New therapeutic use
GB201410387D0 (en)	2014-07-23	Compounds and their therapeutic use
GB201403496D0 (en)	2014-04-16	Compounds and their therapeutic use